Endocytosis of tight junctions caveolin nitrosylation dependent is improved by cocoa via opioid receptor on RPE cells in diabetic conditions

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 9, 2014, Pages 6090-6100

  Rosales, Mariana Aparecida B ^a   Silva, Kamila Cristina ^a   Duarte, Diego A ^a   Rossato, Franco Aparecido ^a   De Faria, José B Lopes ^a   De Faria, Jacqueline M Lopes ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cocoa; High glucose; Nitrosative stress; RPE; Tight junction

Indexed keywords

ALBUMIN; CAVEOLIN; CLAUDIN 1; DEXTRAN; DICHLORODIHYDROFLUORESCEIN DIACETATE; EPICATECHIN; NITRIC OXIDE SYNTHASE; OCCLUDIN; OPIATE RECEPTOR; POLYPHENOL; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; CAV1 PROTEIN, HUMAN; CAVEOLIN 1; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, HUMAN; OCLN PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BLOOD RETINA BARRIER; CACAO; CELL ISOLATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; ELECTRIC RESISTANCE; ENDOCYTOSIS; GLUCOSE INTAKE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NITROSATIVE STRESS; NITROSYLATION; NONHUMAN; PIGMENT EPITHELIUM; PROTEIN DETERMINATION; SWINE; TIGHT JUNCTION; WESTERN BLOTTING; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; IMPEDANCE; METABOLISM; NITROSATION; PERMEABILITY; PHYSIOLOGY;

ANIMALS; BLOOD-RETINAL BARRIER; BLOTTING, WESTERN; CACAO; CAVEOLIN 1; CELL LINE; CLAUDIN-1; DEXTRANS; ELECTRIC IMPEDANCE; ENDOCYTOSIS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLUCOSE; HUMANS; NITRIC OXIDE SYNTHASE TYPE II; NITROSATION; OCCLUDIN; PERMEABILITY; POLYPHENOLS; REACTIVE OXYGEN SPECIES; RECEPTORS, OPIOID; RETINAL PIGMENT EPITHELIUM; SWINE; TIGHT JUNCTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908108217     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14234     Document Type: Article

References (71)

1. Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48-58.
2. Simo R, Villarroel M, Corraliza L, Hernandez C, Garcia-Ramirez M. The retinal pigment epithelium: something more than a constituent of the blood retinal barrier—implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol. 2010;2010:190724.
3. Xu HZ, Le YZ. Significance of outer blood-retina barrier breakdown in diabetes and ischemia. Invest Ophthalmol Vis Sci. 2011;52:2160–2164.
4. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85:845–881.
5. Eagle RC Jr. Mechanisms of maculopathy. Ophthalmology. 1984;91:613–625.
6. Dorey CK, Wu G, Ebenstein D, Garsd A, Weiter JJ. Cell loss in the aging retina: relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci. 1989;30: 1691–1699.
7. Vinores SA, Gadegbeku C, Campochiaro PA, Green WR. Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol. 1989;134:231-235.
8. Hewitt AT, Adler R. Retina: Basic Science and Inherited Retinal Disease. 1st ed. St. Louis: Mosby; 1989;58–71.
9. Pautler EL, Ennis SR. The effect of induced diabetes on the electroretinogram components of the pigmented rat. Invest Ophthalmol Vis Sci. 1980;19:702–705.
10. Samuels IS, Lee CA, Petrash JM, Peachey NS, Kern TS. Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease. Vis Neurosci. 2012; 29:267–274.
11. Villarroel M, García-Ramírez M, Corraliza L, Hernández C, Simó R. High glucose concentration leads to differential expression of tight junction proteins in human retinal pigment epithelial cells. Endocrinol Nutr. 2009;56:53–58.
12. Silva KC, Rosales MA, Hamassaki DE, et al. Green tea is neuroprotective in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2013;54:1325–1336.
13. Marchiando AM, Shen L, Graham WV, et al. Caveolin-1- dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol. 2010;189:111-126.
14. Parton RG, Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol. 2007;8:185–194.
15. Feltkamp, CA, Van der Waerden AW. Junction formation between cultured normal rat hepatocytes. An ultrastructural study on the presence of cholesterol and the structure of developing tight-junction strands. J Cell Sci. 1983;63:271–286.
16. Nusrat A, Parkos CA, Verkade P, et al. Tight junctions are membrane microdomains. J Cell Sci. 2000;113:1771–1781.
17. Schubert W, Frank PG, Razani B, Park DS, Chow CW, Lisanti MP. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J Biol Chem. 2001; 276:48619–48622.
18. Itallie CM, Anderson JM. Caveolin binds independently to claudin-2 and occludin. Ann N Y Acad Sci. 2012;1257:103-107.
19. Holtkamp GM, Kijlstra A, Peek R, de Vos AF. Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res. 2001;20: 29–48.
20. Goureau O, Lepoivre M, Becquet F, Courtois Y. Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor b in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation. Proc Natl Acad Sci U S A. 1993;90:4276-4280.
21. Liversidge J, Grabowski P, Ralston S, Benjamin N, Forrester JV. Rats’ retinal pigment epithelial cells express an inducible form of nitric oxide synthase and produce nitric oxide in response to inflammatory cytokines and activated T cells. Immunology. 1994;83:404–409.
22. Yuan Z, Feng W, Hong J, Zheng Q, Shuai J, Ge Y. p38MAPK and ERK promote nitric oxide production in cultured human retinal pigmented epithelial cells induced by high concentration glucose. Nitric Oxide. 2009;20:9–15.
23. Husain S, Liou GI, Crosson CE. Opioid-receptor-activation: suppression of ischemia/reperfusion-induced production of TNF-alpha in the retina. Invest Ophthalmol Vis Sci. 2011;52: 2577–2583.
24. Ramiro-Puig E, Castell M. Cocoa: antioxidant and immunomodulator. Br J Nutr. 2009;101:931–940.
25. Katavic PL, Lamb K, Navarro H, Prisinzano TE. Flavonoids as opioid receptor ligands: identification and preliminary structure- activity relationships. J Nat Prod. 2007;70:1278–1282.
26. Panneerselvam M, Tsutsumi YM, Bonds JA, et al. Dark chocolate receptors: epicatechin-induced cardiac protection is dependent on delta-opioid receptor stimulation. Am J Physiol Heart Circ Physiol. 2010;299:1604–1609.
27. Heimsath EG Jr, Unda R, Vidro E, Muniz A, Villazana-Espinoza ET, Tsin A. ARPE-19 cell growth and cell functions in euglycemic culture media. Curr Eye Res. 2006;31:1073–1080.
28. Costa IS, de Souza GF, de Oliveira MG, Abrahamsohn Ide A. Snitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions. J Antimicrob Chemother. 2013;68:2561–2568.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth. 1983;65:55–63.
30. Garcia-Ramírez M, Villarroel M, Corraliza L, Hernández C, Simó R. Measuring permeability in human retinal epithelial cells (ARPE-19): implications for the study of diabetic retinopathy. Methods Mol Biol. 2011;763:179–194.
31. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J. 1990;300: 230–235.
32. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 1976;72: 248–254.
33. Takeuchi K, Morizane Y, Kamami-Levy C, et al. AMP-dependent kinase inhibits oxidative stress-induced caveolin-1 phosphorylation and endocytosis by suppressing the dissociation between c-Abl and Prdx1 proteins in endothelial cells. J Biol Chem. 2013;288:20581–20591.
34. Azad N, Vallyathan V, Wang L, et al. S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis. J Biol Chem. 2006;281:34124–34134.
35. Flood MT, Gouras P, Kjeldbye H. Growth characteristics and ultrastructure of human retinal pigment epithelium in vitro. Invest Ophthalmol Vis Sci. 1980;19:1309–1320.
36. Guidry C, McFarland RJ, Morris R, Witherspoon CD, Hook M. Collagen gel contraction by cells associated with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1992;33:2429-2435.
37. Klettner A, Roider J. Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways. Invest Ophthalmol Vis Sci. 2008;49: 4523–4527.
38. Elner VM, Burnstine MA, Strieter RM, Kunkel SL, Elner SG. Cell-associated human retinal pigment epithelium interleukin- 8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses. Exp Eye Res. 1997;65:781–789.
39. Ivanov AI, Nusrat A, Parkos CA. Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment. Mol Biol Cell. 2004;15:176–188.
40. Bruewer M, Utech M, Ivanov AI, Hopkins AM, Parkos CA, Nusrat A. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J. 2005;19:923–933.
41. Shen L, Turner JR. Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. Mol Biol Cell. 2005;16:3919–3936.
42. Marchiando AM, Shen L, Graham WV, et al. Caveolin-1- dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. Cell Biol. 2010;189:111–126.
43. Kirchner P, Bug M, Meyer H. Ubiquitination of the N-terminal region of caveolin-1 regulates endosomal sorting by the VCP/ p97 AAA-ATPase. J Biol Chem. 2013;288:7363–7372.
44. Ban Y, Rizzolo LJ. Regulation of glucose transporters during development of the retinal pigment epithelium. Brain Res Dev Brain Res. 2000;121:89–95.
45. Bergersen LJ, Jóhannsson E, Veruki ML, et al. Cellular and subcellular expression of monocarboxylate transporters in the pigment epithelium and retina of the rat. Neuroscience. 1999; 90:319–331.
46. Senanayake PD, Calabro A, Hu JG, et al. Glucose utilization by the retinal pigment epithelium: evidence for rapid uptake and storage in glycogen, followed by glycogen utilization. Exp Eye Res. 2006;83:235–246.
47. Kim DI, Lim SK, Park MJ, Han HJ, Kim GY, Park SH. The involvement of phosphatidylinositol 3-kinase/Akt signaling in high glucose-induced downregulation of GLUT-1 expression in ARPE cells. Life Sci. 2007;80:626–632.
48. Salceda R, Contreras-Cubas C. Ascorbate uptake in normal and diabetic rat retina and retinal pigment. Comp Biochem Physiol C Toxicol Pharmacol. 2007;146:175–179.
49. Minamizono A, Tomi M, Hosoya K. Inhibition of dehydroascorbic acid transport across the rat blood-retinal and -brain barriers in experimental diabetes. Biol Pharm Bull. 2006;29: 2148–2150.
50. Marmorstein AD. The polarity of the retinal pigment epithelium. Traffic. 2001;2:867–872.
51. Frambach DA, Roy CE, Valentine JL, Weiter JJ. Precocious retinal adhesion is affected by furosemide and ouabain. Curr Eye Res. 1989;8:553–556.
52. Crider JY, Yorio T, Sharif NA, Griffin BW. The effects of elevated glucose on Naþ/Kþ-ATPpase of cultured bovine retinal pigment epithelial cells measured by a new nonradioactive rubidium uptake assay. J Ocul Pharmacol Ther. 1997; 13:337–352.
53. Villarroel M, Garcia-Ramirez M, Corraliza L, Hernandez C, Simo R. Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cells. Exp Eye Res. 2009;89: 913–920.
54. Trudeau K, Roy S, Guo W, et al. Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability. Invest Ophthalmol Vis Sci. 2011;52:6348–6354.
55. Yoshikawa T, Ogata N, Izuta H, Shimazawa M, Hara H, Takahashi K. Increased expression of tight junctions in ARPE-19 cells under endoplasmic reticulum stress. Curr Eye Res. 2011;36:1153–1163.
56. Zheng L, Du Y, Miller C, et al. Role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia. 2007;50: 1987–1996.
57. Kronstein R, Seebach J, Grossklaus S, et al. Caveolin-1 opens endothelial cell junctions by targeting catenins. Cardiovasc Res. 2012;93:130–140.
58. Klaassen I, Hughes JM, Vogels IMC, Schalkwijk CG, Van Noorden CJF, Schlingemann RO. Altered expression of genes related to blood–retina barrier disruption in streptozotocin induced diabetes. Exp Eye Res. 2009;89:4–15.
59. Mora RC, Bonilha VL, Shin BC, et al. Bipolar assembly of caveolae in retinal pigment epithelium. Am J Physiol Cell Physiol. 2006;290:832–843.
60. Li X, McClellan ME, Tanito M, et al. Loss of caveolin-1 impairs retinal function due to disturbance of subretinal microenvironment. J Biol Chem. 2012;287:16424–16434.
61. Kirchner P, Bug M, Meyer H. Ubiquitination of the N-terminal region of caveolin-1 regulates endosomal sorting by the VCP/ p97 AAA-ATPase. J Biol Chem. 2013;288:7363–7372.
62. Pradhan AA, Befort K, Nozaki C, Gaveriaux-Ruff C, Kieffer BL. The delta opioid receptor: an evolving target for the treatment of brain disorders. Trends Pharmacol Sci. 2011;32:581–590.
63. Engler MB, Engler MM. The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr Rev. 2006;64:109–118.
64. Ramiro-Puig E, Castell M. Cocoa: antioxidant and immunomodulator. Br J Nutr. 2009;101:931–940.
65. Steffen Y, Schewe T, Sies H. Myeloperoxidase-mediated LDL oxidation and endothelial cell toxicity of oxidized LDL: attenuation by (-)-epicatechin. Free Radic Res. 2006;40: 1076–1085.
66. Granier S, Manglik A, Kruse AC, et al. Structure of the d-opioid receptor bound to naltrindole. Nature. 2012;485:400–404.
67. Panneerselvam M, Ali SS, Finley JC, et al. Epicatechin regulation of mitochondrial structure and function is opioid receptor dependent. Mol Nutr Food Res. 2013;57:1007–1014.
68. Yu S, Fan J, Liu L, Zhang L, Wang S, Zhang J. Caveolin-1 upregulates integrin a2,6-sialylation to promote integrin a5b1- dependent hepatocarcinoma cell adhesion. FEBS Lett. 2013; 587:782–787.
69. Rodriguez-Feo JA, Hellings WE, Moll FL, et al. Caveolin-1 influences vascular protease activity and is a potential stabilizing factor in human atherosclerotic disease. PLoS One. 2008;3:e2612.
70. Cassuto J, Dou H, Czikora I, et al. Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients. Diabetes. 2014;63:1381–1393.
71. Wang Y, Wang X, Lau WB, et al. Adiponectin inhibits TNF-ainduced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation. Circ Res. 2014;28: 792–805.